Evidence map›Paper›PMID 28757899›Full record

ArticleCancer nanotechnology2017

Platinum nanoparticles: an exquisite tool to overcome radioresistance.

Sha Li, Erika Porcel, Hynd Remita, Sergio Marco, Matthieu Réfrégiers, Murielle Dutertre, Fabrice Confalonieri, Sandrine Lacombe

Open access · goldAbstract read
In one paragraph

Article in Cancer nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Application of Radiosensitizers in Cancer Radiotherapy.International journal of nanomedicine · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Sha LiCNRS, UMR 8214, Institut des Sciences Moléculaires d'Orsay, Université Paris Sud, 91405 Orsay Cedex, France.
Erika PorcelCNRS, UMR 8214, Institut des Sciences Moléculaires d'Orsay, Université Paris Sud, 91405 Orsay Cedex, France.
Hynd RemitaCNRS, UMR 8000, Laboratoire de Chimie Physique, Université Paris-Sud, 91405 Orsay Cedex, France.
Sergio MarcoInstitut Curie/INSERM U759, Campus Universitaire d'Orsay, 91405 Orsay Cedex, France.
Matthieu RéfrégiersSynchrotron SOLEIL, BP48, Saint-Aubin, 91192 Gif-sur-Yvette, France.
Murielle DutertreCEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Univ. Paris-Sud, Université Paris Saclay, 91405 Orsay, France.
Fabrice ConfalonieriCEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Univ. Paris-Sud, Université Paris Saclay, 91405 Orsay, France.
Sandrine LacombeCNRS, UMR 8214, Institut des Sciences Moléculaires d'Orsay, Université Paris Sud, 91405 Orsay Cedex, France.
Institut des Sciences Moléculaires d'Orsay · FRInstitut de Biologie Intégrative de la Cellule · FRInstitut Curie · FRLaboratoire de Chimie Physique · FRSynchrotron soleil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroudSmall metallic nanoparticles are proposed as potential nanodrugs to optimize the performances of radiotherapy. This strategy, based on the enrichment of tumours with nanoparticles to amplify radiation effects in the tumour, aims at increasing the cytopathic effect in tumours while healthy tissue is preserved, an important challenge in radiotherapy. Another major cause of radiotherapy failure is the radioresistance of certain cancers. Surprisingly, the use of nanoparticles to overcome radioresistance has not, to the best of our knowledge, been extensively investigated. The mechanisms of radioresistance have been extensively studied using

methodsIn this work, we investigated the impact of ultra-small platinum nanoparticles (1.7 nm) on this organism, including uptake, toxicity, and effects on radiation responses.

resultsWe showed that the nanoparticles penetrate

conclusionsFinally, this study demonstrates the capacity of metallic nanoparticles to amplify radiation in radioresistant organisms, thus opening the perspective to use nanoparticles not only to improve tumour targeting but also to overcome radioresistance.

Indexed as

Deinococcus radioduransMetallic nanoparticlesRadio-enhancementRadioresistanceRadiosensitization

Identifiers

PMID28757899
PMCPMC5506239
OpenAlexW2736040382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.